A $7.5 million grant from the U.S. Department of Defense will support research by Indiana University scientist and collaborators across the country into AI’s potential to strengthen the psychological impact of online communications, such as misinformation and radicalizing messages, potentially leading to methods to counteract their influence.
An Indiana University School of Medicine physician scientist is making strides in understanding the molecular origins of fatty liver disease, a leading cause of liver failure in the United States.
The largest study of early-onset Alzheimer's disease in the United States is expanding internationally, becoming one of the largest programs of its kind in the world.
Researchers at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center have completed the most extensive mapping of healthy breast cells to date. These findings offer an important tool for researchers at IU and beyond to understand how breast cancer develops and the differences in breast tissue among genetic ancestries.
Researchers in linguistics and mathematics are working to adapt the natural language processing algorithms that power AI’s ability to interact with people using normal speech to quantum computers.
Workplace mistreatment results in higher rates of depression and sleep loss in Black employees than white employees according to research from the Indiana University Kelley School of Business in Bloomington.
Indiana University School of Medicine researchers have made a significant breakthrough in developing a new gene therapy approach that restores full-length dystrophin protein, which could lead to new treatments for people with Duchenne muscular dystrophy (DMD).
New research from the Indiana University Kelley School of Business explains how pharmaceutical companies were able to saturate the country with massive quantities of opioids, despite efforts by the Drug Enforcement Administration to regulate their supply.
Indiana University School of Medicine researchers and their collaborators have uncovered molecular insights expected to enhance treatment options for acute myeloid leukemia (AML), a rare and severe blood and bone marrow cancer.
Indiana University School of Medicine’s Yoshikazu Imanishi, PhD, was recently awarded a four-year, $2.1 million grant from the National Eye Institute and a three-year, $500,000 grant from the Foundation Fighting Blindness to study genetic causes of blindness.
In a paper forthcoming in the Journal of Finance, professors at the Indiana University Kelley School of Business, studied firm-level exposures to hurricanes over a 24-year period to better understand how extreme weather events impact performance in financial markets as measured by option and stock prices.
Researchers at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center and the IU School of Medicine have discovered that Black patients with breast cancer who are treated with a chemotherapy called docetaxel experience less of a harmful side effect called peripheral neuropathy. Their findings represent an important shift in knowledge about a patient population who've historically been underrepresented in breast cancer research.
Researchers will showcase promising respiratory disease research at the American Thoracic Society (ATS) 2024 International Conference and ATS 2024 Respiratory Innovation Summit (RIS), May 17-22 in San Diego, California.
Researchers have discovered a protein marker to help identify cells able to repopulate in patients with damaged blood vessels. Their findings, recently published in Circulation, could lead to new therapies for people with endothelial dysfunction, a type of disorder that contributes to coronary artery disease that may occlude with plaque and lack ability to carry sufficient blood into the heart tissue causing a heart attack.
Indiana University School of Medicine scientists are on a mission to understand why hematopoietic stem cells, responsible for producing all types of mature blood cells, exhibit better responses in a low-oxygen environment within the bone marrow, also known as hypoxia.
A new study led by Indiana University School of Medicine researchers found a brain network condition called “explosive synchronization” could be the cause of extreme pain crises in people with sickle cell disease.
A new $4.8 million grant will support researchers from Indiana University School of Medicine and the Medical Research Council Laboratory of Molecular Biology to study how human neurodegenerative diseases are affected by the misfolding of the protein TDP-43.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
